Marker Therapeutics, Inc. (MRKR)
1.50
+0.11
(+7.91%)
USD |
NASDAQ |
Aug 24, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.4706 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.3414 |
| June 30, 2022 | 0.4124 |
| March 31, 2022 | 0.3282 |
| December 31, 2021 | 0.2698 |
| September 30, 2021 | 0.2298 |
| June 30, 2021 | 0.1917 |
| March 31, 2021 | 0.1682 |
| December 31, 2020 | 0.4482 |
| September 30, 2020 | 0.3996 |
| June 30, 2020 | 0.2747 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.011 |
| December 31, 2019 | 0.011 |
| September 30, 2019 | 0.0111 |
| June 30, 2019 | 0.0113 |
| March 31, 2019 | 0.0112 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0072 |
| June 30, 2018 | 0.0012 |
| March 31, 2018 | 0.0081 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.0008 |
| June 30, 2017 | 0.0006 |
| March 31, 2017 | 0.0012 |
| December 31, 2016 | 0.0008 |
| September 30, 2016 | 0.0007 |
| June 30, 2016 | -0.0014 |
| March 31, 2016 | -0.0011 |
| December 31, 2015 | -0.0025 |
| September 30, 2015 | -0.208 |
| June 30, 2015 | -1.245 |
| March 31, 2015 | -1.472 |
| December 31, 2014 | -0.5419 |
| September 30, 2014 | -0.9582 |
| June 30, 2014 | -0.5407 |
| March 31, 2014 | -0.184 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Krystal Biotech, Inc. | 0.0065 |
| Tenaya Therapeutics, Inc. | 0.0569 |
| Ironwood Pharmaceuticals, Inc. | -2.452 |
| Vericel Corp. | 0.2556 |
| SELLAS Life Sciences Group, Inc. | 0.0054 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.59M |
| Total Liabilities (Quarterly) | 2.42M |
| Shareholders Equity (Quarterly) | 12.17M |
| Current Ratio | 6.027 |